"Stevens-Johnson Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
| Descriptor ID |
D013262
|
| MeSH Number(s) |
C07.465.864.500 C17.800.174.600.900 C17.800.229.400.683 C17.800.865.475.683 C20.543.206.380.900 C25.100.468.380.900
|
| Concept/Terms |
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum- Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
- Stevens Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
- Toxic Epidermal Necrolysis Stevens-Johnson Syndrome Spectrum
- Toxic Epidermal Necrolysis Stevens Johnson Syndrome
- Toxic Epidermal Necrolysis Stevens Johnson Syndrome Spectrum
- Toxic Epidermal Necrolysis Stevens-Johnson Syndrome
- Stevens Johnson Syndrome Toxic Epidermal Necrolysis
- Stevens-Johnson Syndrome Toxic Epidermal Necrolysis
Mycoplasma-Induced Stevens-Johnson Syndrome- Mycoplasma-Induced Stevens-Johnson Syndrome
- Mycoplasma Induced Stevens Johnson Syndrome
- Stevens-Johnson Syndrome, Mycoplasma-Induced
- Syndrome, Mycoplasma-Induced Stevens-Johnson
- Mycoplasma-Induced Stevens Johnson Syndrome
Drug-Induced Stevens Johnson Syndrome- Drug-Induced Stevens Johnson Syndrome
- Drug Induced Stevens Johnson Syndrome
- Drug-Induced Stevens-Johnson Syndrome
- Drug-Induced Stevens-Johnson Syndromes
- Stevens-Johnson Syndrome, Drug-Induced
- Stevens-Johnson Syndromes, Drug-Induced
Epidermal Necrolysis, Toxic- Epidermal Necrolysis, Toxic
- Epidermal Necrolyses, Toxic
- Necrolyses, Toxic Epidermal
- Necrolysis, Toxic Epidermal
- Toxic Epidermal Necrolyses
- Toxic Epidermal Necrolysis
- Scalded Skin Syndrome, Nonstaphylococcal
- Lyell's Syndrome
- Lyell Syndrome
- Lyell's Syndromes
- Syndrome, Lyell's
- Syndromes, Lyell's
- Nonstaphylococcal Scalded Skin Syndrome
|
Below are MeSH descriptors whose meaning is more general than "Stevens-Johnson Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Stevens-Johnson Syndrome".
This graph shows the total number of publications written about "Stevens-Johnson Syndrome" by people in this website by year, and whether "Stevens-Johnson Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2007 | 2 | 0 | 2 |
| 2012 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Stevens-Johnson Syndrome" by people in Profiles.
-
Dastgheib L, Rostami F, Gharesi-Fard B, Asadi-Pooya AA, Namjoo S, Tahmasebi F, Hadibarhaghtalab M. Association of Human Leukocyte Antigen Alleles with Carbamazepine- or Lamotrigine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in an Iranian Population: A Case-control Study. Iran J Med Sci. 2023 Jan; 48(1):70-76.
-
Anderson HJ, Lee JB. A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption. Medicina (Kaunas). 2021 Sep 01; 57(9).
-
Choi H, Mohit B. Cost-effectiveness of screening for HLA-B*1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States. Epilepsia. 2019 07; 60(7):1472-1481.
-
Wolf R, Parish JL, Parish LC. The rash that presents as target lesions. Clin Dermatol. 2019 Mar - Apr; 37(2):148-158.
-
Dunn J. Genetics and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: What Have We Learned? JAMA Ophthalmol. 2017 04 01; 135(4):361-362.
-
Jutkowitz E, Dubreuil M, Lu N, Kuntz KM, Choi HK. The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States. Semin Arthritis Rheum. 2017 04; 46(5):594-600.
-
Gervasio KA, Wu AY. Diagnostic Delay and Amniotic Membrane Transplantation in a Child With Atypical Stevens-Johnson Syndrome. J Pediatr Ophthalmol Strabismus. 2015 Aug 19; 52 Online:e41-4.
-
Burke PA, Malebranche L, Gakhal M, Rahman E, Saltzberg M. Sustained improvement of cardiac function with immunosuppressive therapy in a case of acute lymphocytic myocarditis secondary to allopurinol induced Stevens-Johnson syndrome. Del Med J. 2012 Dec; 84(12):381-3.
-
Selbst SM, Osterhoudt K. Pediatric emergency medicine: legal briefs. Pediatr Emerg Care. 2012 Dec; 28(12):1402-5.
-
Parrillo SJ. Stevens-Johnson syndrome and toxic epidermal necrolysis. Curr Allergy Asthma Rep. 2007 Jul; 7(4):243-7.